Tuesday, Oct 21st

Last update09:17:02 AM GMT






You are here: BioMedTech


Biotech entrepreneur receives lifetime achievement award

From left to right – Steve Bates, BIA CEO, Andy Richards, BIA Lifetime Achievement Award winner, and Tim Edwards, BIA chairman.Cambridge life sciences entrepreneur Dr Andy Richards received the BioIndustry Association Lifetime Achievement Award at the Association’s annual gala dinner.

One Nucleus takes lead in challenging environment

Harriet Fear, CEO of One NucleusIt continues to be a challenging environment for the sector and One Nucleus remains mindful of the need to work very hard to ensure that all our activities provide a tangible benefit for members. With this in mind the company has two brand new initiatives, writes One Nucleus CEO, Harriet Fear.

Accelrys acquisition could stack up to $10 million

Accelrys President and CEO Max Carnecchia. Image courtesy of AccelrysNasdaq-quoted Accelrys, Inc, which has a major presence in Cambridge, has paid around $5 million cash for a long-term Swiss partner. The deal could eventually stack up to $10m based on future performance increments.

Telehealth to reach 1.8 million patients by 2017

Theo Ahadome, senior analyst at InMedicaIn 2012 there was estimated to be 308,000 patients remotely monitored by their healthcare provider for congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), diabetes, hypertension and mental health conditions worldwide. The majority of these were post-acute patients who have been hospitalised and discharged.

DNA store in a teacup

ick Goldman. Image courtesy – EMBL PhotolabResearchers at the EMBL-European Bioinformatics Institute (EMBL-EBI) in Cambridge UK have created a way to store data in the form of DNA – a material that lasts for tens of thousands of years.

Abcam eyes fresh acquisitions

Abcam CEO Jonathan MilnerAntibodies technology powerhouse Abcam expects to report revenue growth of around 28 per cent for the half-year to December 31 despite global uncertainty.

US giants tap into Cambridge biotech

One Nucleus CEO Harriet FearTwo major US companies have signed partnership deals with One Nucleus, the organisation that drives the Cambridge UK biomedical technology cluster.

Protein key to cheaper drugs

Dr Paul RodgersIthaka Life Sciences has teamed up with De Montfort University in the UK to market new technology designed to accelerate and cut the cost of developing new drugs and medicines.

Page 52 of 129